Zydus Lifesciences informs about press release

16 Jan 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated January 16, 2023 titled ‘Zydus receives tentative approval from the USFDA for Levomilnacipran Extended-Release Capsules’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

884.00 -16.25 (-1.81%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×